- Raised $100k grant led by Israel Innovation Authority, Jan 2020
About
Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. The company's technology will use CRISPR to genetically modify the patient's own stem cells, which are then treated by Crispr Stem & Therapeutics protocol and implanted in the patient with acute ischemic heart disease. The company's protocol was tested in several proof-of-concept experiments both in vitro and in vivo in animal models and showed dramatically decreased damage to the heart. The protocol aims to increase patients' life expectancy and quality of life, enable quick recovery, shorten hospitalization, and eliminate the risk of rejection. The company received recognition from the Israeli Innovation Authority (Tnufa funding) and European Commission with two Seals of Excellence.
Funding history · 1 round · $100K total
Q&A
- What is Crispr Stem & Therapeutics (CST) developing?
- Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict heart damage following acute heart attack and chronic heart failure.
- When was Crispr Stem & Therapeutics (CST) founded?
- Crispr Stem & Therapeutics (CST) was founded in May 2018.
- How many employees does Crispr Stem & Therapeutics (CST) have?
- Crispr Stem & Therapeutics (CST) has 1-10 employees.
- What was Crispr Stem & Therapeutics (CST)'s last funding round?
- Crispr Stem & Therapeutics (CST) received a Grant round in January 2020, with the Israel Innovation Authority as a lead investor.
- What is the total amount of funding Crispr Stem & Therapeutics (CST) has raised?
- Crispr Stem & Therapeutics (CST) has raised a total of $100,000 USD.
- Where is Crispr Stem & Therapeutics (CST) headquartered?
- Crispr Stem & Therapeutics (CST) is headquartered in Petah Tikva, Israel.
- Who is the Founder & CEO of Crispr Stem & Therapeutics (CST)?
- Dr. Dalia El-Ani is the Founder & CEO of Crispr Stem & Therapeutics (CST).
- Has Crispr Stem & Therapeutics (CST) received any notable recognition?
- Crispr Stem & Therapeutics (CST) received recognition from the Israeli Innovation Authority (Tnufa funding) and two Seals of Excellence from the European Commission.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | crisprstemtherapeutics.com/ |
|---|---|
| linkedin.com/company/74934002 |
Identifiers & details
| Former names | CRISPR THERAPEUTICS |
|---|---|
| Founded | 2018-5 |
| Employees (exact) | 1 |
Radar intelligence
Web history (Wayback)
| Domain | crisprstemtherapeutics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|